ICT - MILSTEIN   05483
INSTITUTO DE CIENCIA Y TECNOLOGIA "DR. CESAR MILSTEIN"
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Use of monoclonal antibodies for rapid characterization of field oubreaks of FMDV
Autor/es:
MALIRAT V.; BERGMANN I.E.; SEKI, C; ROBIOLO, B; PERIOLO, O; PEREZ BEASCOECHEA, C.; MARADEI, E; MATTION, N; LA TORRE, J. L.
Lugar:
Berlin
Reunión:
Simposio; 16th Intern. Symposium of the World Association; 2013
Institución organizadora:
World Association of Veterinary Laboratory Diagnosticians (WAVLD)
Resumen:
Purpose
Panels of monoclonal antibodies (MAbs) developed against different foot-and-mouth
disease virus (FMDV) vaccine strains previously characterized were used for in process
control and evaluation of commercial vaccines. Here we described a rapid method to
analyze the evolution of field strains in viral outbreaks occurred in South America.
Methods
The reactivity with reference strains and field isolates was evaluated by ELISA using
type specific MAbs. Linear antigenic profiles or checkerboard graphs were used to
compare different isolates. Correlation coefficients of reactivity were used for the
comparison of antigenic profiles.
Results
The screening of FMDV field isolates from the 2000?2001 outbreaks in Argentina
based on these correlation coefficients was capable to identify two main groups of
FMDV isolates and the transient presence of other minor variants. During the 2009-2010
outbreaks in Ecuador, a panel of 20 MAbs (raised against O Caseros, O1Campos and O
Taiwan) was used to analyze type O viruses. MAbs? profiling grouped the isolates into
two major reactivity patterns which differed from that of the vaccine strain. The same
type O panel of MAbs was used to analyze isolates from FMDV outbreaks in Paraguay.
Marked differences with the vaccine strain O1/Campos were recognized, including the
loss of reactivity with some neutralizing MAbs.
Conclusions
ELISA carried out using panels of MAbs allows a rapid analysis of strains that are
circulating during outbreaks and helps to determine which isolates are epidemiologically
relevant to be considered for further studies, such as sequencing, cross protection by
neutralization tests, lp-ELISA, and eventually virus challenge in susceptible animals.

